A citation-based method for searching scientific literature

Susanne B Haga, Genevieve Tindall, Julianne M O'Daniel. Genet Test Mol Biomarkers 2012
Times Cited: 38







List of co-cited articles
248 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Primary care physicians' knowledge of and experience with pharmacogenetic testing.
S B Haga, W Burke, G S Ginsburg, R Mills, R Agans. Clin Genet 2012
162
39

Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
E J Stanek, C L Sanders, K A Johansen Taber, M Khalid, A Patel, R R Verbrugge, B C Agatep, R E Aubert, R S Epstein, F W Frueh. Clin Pharmacol Ther 2012
271
34

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
Robert C Green, Jonathan S Berg, Wayne W Grody, Sarah S Kalia, Bruce R Korf, Christa L Martin, Amy L McGuire, Robert L Nussbaum, Julianne M O'Daniel, Kelly E Ormond,[...]. Genet Med 2013
34

Public perspectives about pharmacogenetic testing and managing ancillary findings.
Susanne B Haga, Genevieve Tindall, Julianne M O'Daniel. Genet Test Mol Biomarkers 2012
40
28

Survey of genetic counselors and clinical geneticists' use and attitudes toward pharmacogenetic testing.
S B Haga, J M O'Daniel, G M Tindall, R Mills, I M Lipkus, R Agans. Clin Genet 2012
30
30

Patients' and physicians' perspectives on pharmacogenetic testing.
Anja Rogausch, Daniela Prause, Anne Schallenberg, Jürgen Brockmöller, Wolfgang Himmel. Pharmacogenomics 2006
81
21

Clinical and ethical considerations in pharmacogenetic testing: views of physicians in 3 "early adopting" departments of psychiatry.
Jinger G Hoop, Maria I Lapid, Rene M Paulson, Laura Weiss Roberts. J Clin Psychiatry 2010
45
21

Assessment of the pharmacogenomics educational needs of pharmacists.
Kristen B McCullough, Christine M Formea, Kevin D Berg, Julianna A Burzynski, Julie L Cunningham, Narith N Ou, Maria I Rudis, Joanna L Stollings, Wayne T Nicholson. Am J Pharm Educ 2011
120
21

Patients' and healthcare professionals' views on pharmacogenetic testing and its future delivery in the NHS.
Emily A Fargher, Charlotte Eddy, William Newman, Faieza Qasim, Karen Tricker, Rachel A Elliott, Katherine Payne. Pharmacogenomics 2007
75
21

Development and implementation of a pharmacist-managed clinical pharmacogenetics service.
Kristine R Crews, Shane J Cross, John N McCormick, Donald K Baker, Alejandro R Molinelli, Richard Mullins, Mary V Relling, James M Hoffman. Am J Health Syst Pharm 2011
101
18

Exploring concordance and discordance for return of incidental findings from clinical sequencing.
Robert C Green, Jonathan S Berg, Gerard T Berry, Leslie G Biesecker, David P Dimmock, James P Evans, Wayne W Grody, Madhuri R Hegde, Sarah Kalia, Bruce R Korf,[...]. Genet Med 2012
122
18

Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions.
Susanne B Haga, Julianne M O'Daniel, Genevieve M Tindall, Isaac R Lipkus, Robert Agans. Genet Med 2011
41
18

Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project.
J M Pulley, J C Denny, J F Peterson, G R Bernard, C L Vnencak-Jones, A H Ramirez, J T Delaney, E Bowton, K Brothers, K Johnson,[...]. Clin Pharmacol Ther 2012
271
18

Ancillary risk information and pharmacogenetic tests: social and policy implications.
N B Henrikson, W Burke, D L Veenstra. Pharmacogenomics J 2008
29
20

Managing incidental findings and research results in genomic research involving biobanks and archived data sets.
Susan M Wolf, Brittney N Crock, Brian Van Ness, Frances Lawrenz, Jeffrey P Kahn, Laura M Beskow, Mildred K Cho, Michael F Christman, Robert C Green, Ralph Hall,[...]. Genet Med 2012
302
15



Knowledge, attitudes and education of pharmacists regarding pharmacogenetic testing.
Mary W Roederer, Marcia Van Riper, John Valgus, George Knafl, Howard McLeod. Per Med 2012
50
15

Survey of US public attitudes toward pharmacogenetic testing.
S B Haga, J M O'Daniel, G M Tindall, I R Lipkus, R Agans. Pharmacogenomics J 2012
100
15

Genetics professionals' perspectives on reporting incidental findings from clinical genome-wide sequencing.
Zoe Lohn, Shelin Adam, Patricia Birch, Anne Townsend, Jan Friedman. Am J Med Genet A 2013
42
15

Clinician Perspectives on Using Pharmacogenomics in Clinical Practice.
Kim M Unertl, Habiba Jaffa, Julie R Field, Lisa Price, Josh F Peterson. Per Med 2015
41
15

Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.
Felix W Frueh, Shashi Amur, Padmaja Mummaneni, Robert S Epstein, Ronald E Aubert, Teresa M DeLuca, Robert R Verbrugge, Gilbert J Burckart, Lawrence J Lesko. Pharmacotherapy 2008
180
13

Survey on warfarin pharmacogenetic testing among anticoagulation providers.
Maha Kadafour, Roshanak Haugh, Monica Posin, Steven R Kayser, Jaekyu Shin. Pharmacogenomics 2009
26
19

Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19.
J J Swen, T van der Straaten, J A M Wessels, M L Bouvy, E E W Vlassak, W J J Assendelft, H-J Guchelaar. Eur J Clin Pharmacol 2012
27
18


Managing incidental findings in human subjects research: analysis and recommendations.
Susan M Wolf, Frances P Lawrenz, Charles A Nelson, Jeffrey P Kahn, Mildred K Cho, Ellen Wright Clayton, Joel G Fletcher, Michael K Georgieff, Dale Hammerschmidt, Kathy Hudson,[...]. J Law Med Ethics 2008
469
13

The incidentalome: a threat to genomic medicine.
Isaac S Kohane, Daniel R Masys, Russ B Altman. JAMA 2006
214
13

Motivators for participation in a whole-genome sequencing study: implications for translational genomics research.
Flavia M Facio, Stephanie Brooks, Johanna Loewenstein, Susannah Green, Leslie G Biesecker, Barbara B Biesecker. Eur J Hum Genet 2011
97
13

"I want to know what's in Pandora's Box": comparing stakeholder perspectives on incidental findings in clinical whole genomic sequencing.
Anne Townsend, Shelin Adam, Patricia H Birch, Zoe Lohn, Francois Rousseau, Jan M Friedman. Am J Med Genet A 2012
120
13

Insurance coverage policies for personalized medicine.
Andrew Hresko, Susanne B Haga. J Pers Med 2012
59
13

Electronic health record design and implementation for pharmacogenomics: a local perspective.
Josh F Peterson, Erica Bowton, Julie R Field, Marc Beller, Jennifer Mitchell, Jonathan Schildcrout, William Gregg, Kevin Johnson, Jim N Jirjis, Dan M Roden,[...]. Genet Med 2013
66
13

Recommendations for returning genomic incidental findings? We need to talk!
Wylie Burke, Armand H Matheny Antommaria, Robin Bennett, Jeffrey Botkin, Ellen Wright Clayton, Gail E Henderson, Ingrid A Holm, Gail P Jarvik, Muin J Khoury, Bartha Maria Knoppers,[...]. Genet Med 2013
212
13

Attitudes of clinicians following large-scale pharmacogenomics implementation.
J F Peterson, J R Field, Y Shi, J S Schildcrout, J C Denny, T L McGregor, S L Van Driest, J M Pulley, I M Lubin, M Laposata,[...]. Pharmacogenomics J 2016
49
13

Context, ethics and pharmacogenetics.
Adam M Hedgecoe. Stud Hist Philos Biol Biomed Sci 2006
24
16


Consumers' views of pharmacogenetics--A qualitative study.
Catherine A Haddy, Helena M Ward, Manya T Angley, Ross A McKinnon. Res Social Adm Pharm 2010
34
11

Potential roles for pharmacists in pharmacogenetics.
Shareen Y El-Ibiary, Christine Cheng, Brian Alldredge. J Am Pharm Assoc (2003) 2008
25
16

Pharmacogenomics in the curricula of colleges and schools of pharmacy in the United States.
John E Murphy, James S Green, Laura A Adams, Robert B Squire, Grace M Kuo, Alan McKay. Am J Pharm Educ 2010
88
10

A critical analysis of barriers to the clinical implementation of pharmacogenomics.
Ross A McKinnon, Michael B Ward, Michael J Sorich. Ther Clin Risk Manag 2007
38
10

Pharmacogenomics in a community pharmacy: ACT now.
Lisa Padgett, Shanna O'Connor, Mary Roederer, Howard McLeod, Stefanie Ferreri. J Am Pharm Assoc (2003) 2011
27
14

To tell or not to tell? A systematic review of ethical reflections on incidental findings arising in genetics contexts.
Gabrielle M Christenhusz, Koenraad Devriendt, Kris Dierickx. Eur J Hum Genet 2013
106
10

Researcher perspectives on disclosure of incidental findings in genetic research.
Meredith C Meacham, Helene Starks, Wylie Burke, Kelly Edwards. J Empir Res Hum Res Ethics 2010
51
10


Genetics specialists' perspectives on disclosure of genomic incidental findings in the clinical setting.
Nancy R Downing, Janet K Williams, Sandra Daack-Hirsch, Martha Driessnack, Christian M Simon. Patient Educ Couns 2013
41
10


Informed consent and genomic incidental findings: IRB chair perspectives.
Christian M Simon, Janet K Williams, Laura Shinkunas, Debra Brandt, Sandra Daack-Hirsch, Martha Driessnack. J Empir Res Hum Res Ethics 2011
35
11

Researcher and institutional review board chair perspectives on incidental findings in genomic research.
Janet K Williams, Sandra Daack-Hirsch, Martha Driessnack, Nancy Downing, Laura Shinkunas, Debra Brandt, Christian Simon. Genet Test Mol Biomarkers 2012
27
14

Exploratory planning and implementation of a pilot pharmacogenetic program in a community pharmacy.
Shanna K O'Connor, Stefanie P Ferreri, Natasha M Michaels, Angelo J Greco, Anthony J Viera, Hawazin Faruki, Howard L McLeod, Mary W Roederer. Pharmacogenomics 2012
19
21

Development and evaluation of a pharmacogenomics educational program for pharmacists.
Christine M Formea, Wayne T Nicholson, Kristen B McCullough, Kevin D Berg, Melody L Berg, Julie L Cunningham, Julianna A Merten, Narith N Ou, Joanna L Stollings. Am J Pharm Educ 2013
52
10

Genomics and drug response.
Liewei Wang, Howard L McLeod, Richard M Weinshilboum. N Engl J Med 2011
375
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.